Indogulf FY26 net profit rises 27% to ₹400 crore

2 min read     Updated on 03 Jun 2026, 03:50 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Indogulf Cropsciences Limited reported a 27.3% rise in FY26 net profit to ₹400.27 crore, with revenue growing 19.3% to ₹7,046.33 crore. The company's EBITDA increased 15% to ₹740 crore. Management highlighted growth in exports, particularly to Latin America, and improved capacity utilization to 52%. The company is focusing on high-margin specialty products and expanding its distribution network.

powered bylight_fuzz_icon
40984918

*this image is generated using AI for illustrative purposes only.

Indogulf Cropsciences Limited reported a 27.3% year-on-year rise in consolidated net profit to ₹400.27 crore for the financial year ended March 31, 2026. Revenue from operations for the year grew 19.3% to ₹7,046.33 crore, driven by distribution expansion and export growth. For the quarter ended March 31, 2026, net profit stood at ₹116.12 crore, while revenue was ₹1,508.18 crore. The company’s EBITDA for FY26 increased 15% to ₹740 crore, with margins at 10.4%.

The Board of Directors, in its meeting held on May 28, 2026, approved the audited standalone and consolidated financial results. Devesh Parekh & Co., Chartered Accountants, issued an unmodified opinion on the results. The board recommended the appointment of M/s NJ & Associates as Secretarial Auditors for a term of five years commencing from FY 2026-27, subject to shareholder approval. Additionally, the board appointed M/s Jain Sharma & Associates as Cost Auditors and M/s T Jain and Associates as Internal Auditors for FY 2026-27.

Key Financial Metrics

Metric Q4 FY26 (₹ in million) Q4 FY25 (₹ in million) FY26 (₹ in million) FY25 (₹ in million)
Revenue from Operations 1,508.18 1,262.33 7,046.33 5,904.21
EBITDA (Excl. Other Income) 204 208 740 643
Profit for the Period 116.12 97.95 400.27 314.72
EPS (₹) 2.30 2.01 6.72 6.45

Strategic Outlook

The company outlined its strategy to evolve from an agrochemical company into an integrated agri-solutions platform. Key focus areas include increasing the contribution of high-margin specialty products, strengthening operational excellence through procurement and supply chain efficiency, and expanding its portfolio of biologicals and sustainable crop solutions. Indogulf aims to accelerate global expansion by entering new markets and significantly growing export revenues, supported by 990 total registrations across various geographies.

Operational Highlights

Indogulf’s manufacturing capabilities are spread across four facilities located in Nathupur (I & II), Barwasni, and Samba, with a total capacity exceeding 44,000 MT/KL/TPA. The company reported a capacity utilization rate of 52% for FY26. Its diversified product portfolio spans crop protection (85% of revenue share), plant nutrients (5%), and biologicals (6%). The company also emphasized its deepening farmer engagement model, which includes product demonstrations, advisory-led consultations, and field trials to drive long-term value creation.

Business Performance

The company expanded its export presence with entry into newer geographies including Venezuela, Taiwan, and Sudan, marking its entry into the Latin American market with a fertilizer shipment to Venezuela. Distribution strength was bolstered by a network of 7,000+ distributors and 192 active institutional business partners. Additionally, Indogulf signed a MoA under the Prime Minister's Fellowship for Doctoral Research with ICAR-IARI to support research-led agricultural innovation.

Sanjay Aggarwal, Managing Director, Indogulf Cropsciences Ltd, stated that the company delivered resilient growth supported by disciplined execution and improving product mix. He highlighted the expansion into Latin America and the scaling of operations by AGPL. Aggarwal noted that while the industry environment remains dynamic due to weather-related uncertainties and raw material volatility, the company is proactively managing procurement and supply chain operations. He added that capacity utilization improved steadily during the year, supported by better operational efficiencies.

What specific measures is Indogulf taking to increase capacity utilization from the current 52% to drive higher operational leverage?

How will the strategic shift toward high-margin specialty products and biologicals impact the company's overall EBITDA margins over the next three years?

What are the revenue growth targets for the newly entered Latin American and African markets compared to established geographies?

Indogulf Cropsciences Reports No Deviation in IPO Fund Utilisation for Quarter Ended March 31, 2026

3 min read     Updated on 13 May 2026, 09:51 AM
scanx
Reviewed by
Shraddha JScanX News Team
AI Summary

Indogulf Cropsciences Limited filed its Third Monitoring Agency Report for the quarter ended March 31, 2026, prepared by Brickwork Ratings India Private Limited, confirming no deviation in the utilisation of IPO proceeds from its ₹200 Crore issue. Fund utilisation across all objects — including working capital, borrowing repayment, DF plant capex, general corporate purposes, and issue expenses — was verified by M/s Devesh Parekh & Co., with unutilised proceeds deployed in bank accounts and financial instruments.

powered bylight_fuzz_icon
40110991

*this image is generated using AI for illustrative purposes only.

Indogulf Cropsciences Limited has filed its Third Monitoring Agency Report and Statement of Deviation or Variation for the quarter and year ended March 31, 2026, with BSE Limited and National Stock Exchange of India Limited. The filing, dated May 12, 2026, was made pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The monitoring report was prepared by Brickwork Ratings India Private Limited, and confirms no deviation or variation in the utilisation of IPO proceeds.

IPO Issue Details

The company raised funds through a Fresh Issue and Offer for Sale of Equity Shares, with allotment completed on July 1, 2025. The issue was open for anchor investors from June 25, 2025 to June 30, 2025, and for other investors from June 25, 2025 to June 26, 2025. The following table summarises the issue details:

Parameter: Details
Issue Type: Fresh Issue and Offer for Sale of Equity Shares
Total Issue Size: ₹200 Crore
Fresh Issue Size: ₹160 Crore
Offer for Sale Size: ₹40 Crore
Issue Price: ₹111 per share
Date of Allotment: July 1, 2025
Monitoring Agency: Brickwork Ratings India Private Limited

The total number of equity shares issued aggregated to 1,80,77,476, comprising 1,44,73,873 shares under the Fresh Issue and 36,03,603 shares under the Offer for Sale. The amount received matched the value as per the Offer Document in both categories.

Fund Utilisation Progress as at March 31, 2026

Brickwork Ratings confirmed that all utilisation is as per the disclosures in the Offer Document, with no material deviation observed. The following table details the progress in utilisation of IPO proceeds across each object:

Item Head: Proposed Amount (₹ Crore) Amount Utilised — End of Quarter (₹ Crore) Unutilised Amount (₹ Crore)
Funding working capital requirements 65.00 68.91 -3.91
Repayment/prepayment of outstanding borrowings 34.12 33.85 0.26
Capital expenditure for DF plant at Barwasni, Sonipat, Haryana 14.00 3.40 10.60
General corporate purposes 27.85 27.25 0.60
Issue expenses 19.03 16.33 2.70

The above details were verified by M/s Devesh Parekh & Co., Chartered Accountants, vide CA certificate dated May 11, 2026, and company statement dated May 11, 2026. It is noted that out of ₹15.38 Crore utilised towards issue expenses for the quarter ended September 30, 2025, the company took reimbursement of ₹2.40 Crore towards issue-related expenses incurred prior to the date of issue.

Deployment of Unutilised Proceeds

Unutilised IPO proceeds have been deployed across bank accounts and financial instruments as at the end of the quarter. The deployment details are as follows:

Instrument / Entity: Amount Invested (₹ Crore) Market Value — End of Quarter (₹ Crore)
Public Offer A/c – 57500001799570 0.00 -
Monitoring A/c – 57500001798899 0.28 -
Invesco India Arbitrage Direct-G 1.12 1.17
Invesco India Arbitrage Reg-G 0.50 0.51
Vivriti Capital Ltd – Commercial Paper (Maturity: April 22, 2026) 9.79 9.94

Implementation Status and Deviation Statement

The monitoring report confirms that no delay has been observed in the implementation of objects relative to the timelines stated in the Offer Document. Working capital funding has been completed, while repayment of borrowings, capital expenditure for the dry flowable (DF) plant at Barwasni, general corporate purposes, and issue expenses remain ongoing, all within the target of Financial Year 2025-26 as per the Offer Document.

The Statement of Deviation or Variation, filed alongside the monitoring report, confirms that there is no deviation or variation in the use of funds raised. The Audit Committee and auditors have raised no comments. General corporate purpose utilisation during the quarter stood at ₹2.25 Crore as on March 31, 2026, directed towards strategic initiatives, marketing and brand building, and general corporate exigencies, among other board-approved purposes. The report was signed by Sakshi Jain, Company Secretary and Compliance Officer, and is available on the company's website at www.groupindogulf.com .

Given that working capital utilisation has already exceeded the proposed amount by ₹3.91 Crore, how might Indogulf Cropsciences fund any additional working capital needs in FY2026-27 without diluting equity or increasing debt?

With only ₹3.40 Crore of the ₹14 Crore allocated for the DF plant at Barwasni deployed by March 2026, what is the revised timeline for completion and how could delays impact the company's production capacity and revenue targets?

How might the maturity of the Vivriti Capital Commercial Paper investment in April 2026 affect the company's redeployment strategy for unutilised IPO proceeds in the upcoming quarters?

More News on Indogulf Cropsciences